Omron (OTCMKTS:OMRNY) Shares Gap Down – Should You Sell?

Omron Corp. (OTCMKTS:OMRNY) gapped down prior to trading on Thursday. The stock had previously closed at $41.11, but opened at $37.3650. Omron shares last traded at $37.40, with a volume of 2,155 shares changing hands.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, August 10th. Two equities research analysts have rated the stock with a Hold rating. According to MarketBeat, the company presently has a consensus rating of “Hold”.

Omron Price Performance

The stock has a market cap of $7.47 billion, a price-to-earnings ratio of 34.50, a P/E/G ratio of 0.74 and a beta of 1.22. The company has a current ratio of 1.93, a quick ratio of 1.49 and a debt-to-equity ratio of 0.09. The company’s fifty day moving average is $40.36 and its two-hundred day moving average is $36.56.

Hedge Funds Weigh In On Omron

An institutional investor recently raised its stake in Omron stock. GAMMA Investing LLC boosted its position in Omron Corp. (OTCMKTS:OMRNY) by 12.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,536 shares of the company’s stock after acquiring an additional 382 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $144,000 at the end of the most recent quarter. 1.09% of the stock is currently owned by hedge funds and other institutional investors.

About Omron

Omron Corporation is a Japan-based technology company that develops automation, sensing, control and healthcare solutions. Its products include industrial sensors, controllers, machine-vision and inspection systems, safety equipment, robotics and other factory-automation technologies used to improve manufacturing productivity and quality.

Through its healthcare business, Omron provides blood-pressure monitors, electrocardiographs, nebulizers, body-composition monitors and related digital health services for consumers and medical professionals.